Be First In the Race To deliver breakthrough cell & gene therapies ACCELERATE YOUR SUCCESS When your scientific success means being first; to discover, to publish, to reach the clinic, OXGENE, helps pioneering companies accelerate the discovery and biomanufacture of their CAR-T / Cell Therapies and Gene Therapies; to be first to deliver these breakthrough therapeutics to the patients who need them. Advanced Cell TherapySolutions Promoter DiscoveryPlasmids & Cell LinesTransient LV Production SystemsLV Packaging and Producer Cell Lines Advanced Gene TherapySolutions Plasmids and Cell LinesTransient AAV ProductionTESSA: Scalable AAV Production SUPPORTING A PIONEERING COMMUNITYWe provide pioneering companies with advanced technology and service solutions to accelerate the transition between laboratory research and clinical manufacture. OUR VISIONCutting edge science with purpose. Invention and innovation to advance and improve the development and delivery of cell and gene therapies. OUR MISSIONTo get the benefits of our innovations to the patients who need them. To demonstrate the technical and commercial viability of our innovations, and to integrate them into manufacturing platforms that will provide large scale, global market access. WuXi Advanced Therapies INTEGRATED GMP MANUFACTURING AND TESTING LEARN MORE SUPPORTING A PIONEERING COMMUNITY We provide pioneers with advanced technology and service solutions to accelerate the transition between laboratory research and clinical manufacture. ScientificSuccess Stories05 Jan 2021OXGENE - Cell line developmentOXGENE’s team of cell line engineering experts design a strategy and use our optimised workflow and high throughput screening platform to maximise...Read More 12 Jan 2021OXGENE - iPSCs InfographicHuman induced pluripotent stem cells (iPSCs) are adult cells that have been transformed using a combination of transcription factors to...Read More 18 Mar 2021OXGENE - TESSA InfographicThe challenge of scalable AAV manufacture for gene therapies, and how to overcome it. Gene therapies offer enormous promise for the treatment of...Read More 26 Oct 2021OXGENE Case Study - TiCARosTiCARos Therapeutics has leveraged the expertise of their team of immunologists from Seoul National University, College of Medicine to develop a...Read More 15 Feb 2022OXGENE Case Study - CarismaCancer immunotherapies aim to harness the immune system to fight tumours. Carisma Therapeutics is taking a novel approach to cancer immunotherapy by...Read More OUR MISSION IS TO ACCELERATE SUCCESS 07 Mar 2022Launch of TESSA™ Technology WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies TESSA™ technology provides a...View all NewsEMA GMP Certification for new testing facilityWuXi AppTec acquire OXGENEAccelerating gene therapy developmentWuXi ATU and Wugen Announce Manufacturing Partnership BE FIRST in the race to deliver breakthrough Cell & Gene Therapies CONTACT US Our AwardsOur pioneering spirit drives our success. We're honoured to be recognised in the following awards.